405 related articles for article (PubMed ID: 17162985)
1. Insomnia comorbidity and impact and hypnotic use by age group in a national survey population aged 16 to 74 years.
Stewart R; Besset A; Bebbington P; Brugha T; Lindesay J; Jenkins R; Singleton N; Meltzer H
Sleep; 2006 Nov; 29(11):1391-7. PubMed ID: 17162985
[TBL] [Abstract][Full Text] [Related]
2. Increased prevalence of insomnia and changes in hypnotics use in England over 15 years: analysis of the 1993, 2000, and 2007 National Psychiatric Morbidity Surveys.
Calem M; Bisla J; Begum A; Dewey M; Bebbington PE; Brugha T; Cooper C; Jenkins R; Lindesay J; McManus S; Meltzer H; Spiers N; Weich S; Stewart R
Sleep; 2012 Mar; 35(3):377-84. PubMed ID: 22379244
[TBL] [Abstract][Full Text] [Related]
3. Risk of psychiatric disorders in patients with chronic insomnia and sedative-hypnotic prescription: a nationwide population-based follow-up study.
Chung KH; Li CY; Kuo SY; Sithole T; Liu WW; Chung MH
J Clin Sleep Med; 2015 Apr; 11(5):543-51. PubMed ID: 25766696
[TBL] [Abstract][Full Text] [Related]
4. Insomnia, hypnotic use, and health-related quality of life in a nationally representative sample.
Scalo J; Desai P; Rascati K
Qual Life Res; 2015 May; 24(5):1223-33. PubMed ID: 25432884
[TBL] [Abstract][Full Text] [Related]
5. Insomnia and use of hypnotics: study of a French population.
Quera-Salva MA; Orluc A; Goldenberg F; Guilleminault C
Sleep; 1991 Oct; 14(5):386-91. PubMed ID: 1759090
[TBL] [Abstract][Full Text] [Related]
6. The prevalence of insomnia, its sociodemographic and clinical correlates, and treatment in rural and urban regions of Beijing, China: a general population-based survey.
Xiang YT; Ma X; Cai ZJ; Li SR; Xiang YQ; Guo HL; Hou YZ; Li ZB; Li ZJ; Tao YF; Dang WM; Wu XM; Deng J; Lai KY; Ungvari GS
Sleep; 2008 Dec; 31(12):1655-62. PubMed ID: 19090321
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the safety and efficacy of quazepam for the treatment of insomnia in psychiatric outpatients.
Mendels J
J Clin Psychiatry; 1994 Feb; 55(2):60-5. PubMed ID: 7915708
[TBL] [Abstract][Full Text] [Related]
8. Correlates of benzodiazepine use in individuals with insomnia.
Morin CM; Bélanger L; Bernier F
Sleep Med; 2004 Sep; 5(5):457-62. PubMed ID: 15341890
[TBL] [Abstract][Full Text] [Related]
9. The influence of co-morbidities on prescribing pharmacotherapy for insomnia: evidence from US national outpatient data 1995-2004.
Pawaskar MD; Joish VN; Camacho FT; Rasu RS; Balkrishnan R
J Med Econ; 2008; 11(1):41-56. PubMed ID: 19450109
[TBL] [Abstract][Full Text] [Related]
10. Outcome of new benzodiazepine prescriptions to older adults in primary care.
Simon GE; Ludman EJ
Gen Hosp Psychiatry; 2006; 28(5):374-8. PubMed ID: 16950371
[TBL] [Abstract][Full Text] [Related]
11. A psychiatric perspective on insomnia.
McCall WV
J Clin Psychiatry; 2001; 62 Suppl 10():27-32. PubMed ID: 11388587
[TBL] [Abstract][Full Text] [Related]
12. Role of community pharmacists in the detection of potentially inappropriate benzodiazepines prescriptions for insomnia.
Urru SA; Pasina L; Minghetti P; Giua C
Int J Clin Pharm; 2015 Dec; 37(6):1004-8. PubMed ID: 26198541
[TBL] [Abstract][Full Text] [Related]
13. The daytime impact of DSM-5 insomnia disorder: comparative analysis of insomnia subtypes from the Great British Sleep Survey.
Espie CA; Kyle SD; Hames P; Cyhlarova E; Benzeval M
J Clin Psychiatry; 2012 Dec; 73(12):e1478-84. PubMed ID: 23290331
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and treatment of insomnia in the community: results from the Upper Bavarian Field Study.
Weyerer S; Dilling H
Sleep; 1991 Oct; 14(5):392-8. PubMed ID: 1759091
[TBL] [Abstract][Full Text] [Related]
15. Main neuroendocrine features and therapy in primary sleep troubles.
Amihăesei IC; Mungiu OC
Rev Med Chir Soc Med Nat Iasi; 2012; 116(3):862-6. PubMed ID: 23272543
[TBL] [Abstract][Full Text] [Related]
16. [A connection between insomnia and psychiatric disorders in the French general population].
Ohayon MM; Lemoine P
Encephale; 2002; 28(5 Pt 1):420-8. PubMed ID: 12386543
[TBL] [Abstract][Full Text] [Related]
17. Persistent insomnia in chronic hypnotic users presenting to a sleep medical center: a retrospective chart review of 137 consecutive patients.
Krakow B; Ulibarri VA; Romero E
J Nerv Ment Dis; 2010 Oct; 198(10):734-41. PubMed ID: 20921864
[TBL] [Abstract][Full Text] [Related]
18. Consequences of insomnia and its therapies.
Benca RM
J Clin Psychiatry; 2001; 62 Suppl 10():33-8. PubMed ID: 11388589
[TBL] [Abstract][Full Text] [Related]
19. Association of insomnia severity and comorbid medical and psychiatric disorders in a health plan-based sample: Insomnia severity and comorbidities.
Sarsour K; Morin CM; Foley K; Kalsekar A; Walsh JK
Sleep Med; 2010 Jan; 11(1):69-74. PubMed ID: 19410512
[TBL] [Abstract][Full Text] [Related]
20. Quality of life in older adults receiving medications for anxiety, depression, or insomnia: findings from a community-based study.
Stein MB; Barrett-Connor E
Am J Geriatr Psychiatry; 2002; 10(5):568-74. PubMed ID: 12213691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
